About 60 Trademarks found for “TIDA*”

Cleaning solvents for refineries

Electronic transmission and streaming, including by subscription, of multimedia content namely, audio, video, text and images via the Internet such as music, music videos, and information and news in the field of entertainment relating to music

Petroleum and fuels, namely crude oil and natural gas liquids;

Energy marketing, namely, the direct marketing of crude oil and liquefied natural gas for others; managing the supply and balancing of crude oil and liquefied natural gas; managing the peaking distribution of crude oil and liquefied natural gas; transportation by rail, truck and pipeline and storage of crude oil and liquefied natural gas

Fresh, frozen, canned, smoked and dried seafood.

The Certification mark that we are requesting will be used for the Nova Scotia appellation wine: Tidal Bay. New Appellation White Wine for Nova Scotia - Standards Concept: Fresh, crisp, dryish, still, white with a bright, 'signature Nova Scotia' aromatic component Standards: 1) All grapes used in the making of the wine must be Nova Scotia grown. 2) Permissible Grape Varieties: Permitted grapes would fit into two very general categories: a) Less emphatically aromatic varieties whose relative neutrality serve to enhance the vivid Nova Scotia terroir in the resulting wine, and b) Highly aromatic varieties nevertheless capable, within prescribed maximums, of displaying uniquely Nova Scotian aromatic traits in a blended wine. The Appellation wine is to be composed of grape varieties as follows: a) PRIMARY VARIETIES (which must, alone or in combination, make up a majority of the final blend): L'Acadie Seyval Vidal Geisenheim 318 b) SECONDARY VARIETIES (optional, but must not, alone or in combination, make up more than 49% of the final blend): Riesling Chardonnay Pinot Blanc Pinot Gris Chasselas Auxerrois Kentville White Varieties Ortega Siegerebe Siegfried Geisenheim 319, 322 or 6495-3 Cayuga Minnesota Muscat Petit Milo Frontenac Gris c) TERTIARY VARIETIES (optional, but must not, alone or in combination, make up more than 15% of the final blend; and must not, as determined by the Independent Tasting Panel, overshadow the terroir-based aromatics or flavour of the wine): Gewurztraminer Perle of Csaba Traminette New York Muscat Valvin French-hybrid or vinifera Muscat varieties The Appellation Implementation Committee (AIC) acknowledges that the grapes (and percentages) permitted are those currently felt to most beautifully convey Nova Scotia terroir. Accordingly, it is felt that updating on an ongoing basis, as convincing wines are made, will be important. Wineries may apply to the Technical & Standards Committee to have varieties added to the Secondary or Tertiary list, recognizing that these applications will require submissions and wine samples, and changes may not necessarily be accomplished within a single vintage. 3) Maximum Yields: - An annual, bottled average of 3 Tonnes/Acre (approx. 51hl/h) will be the maximum permitted yield. (* and **) 4) Pressing of the grapes may only be done with a bladder or basket press (vertical or horizontal). 5) Debourbage (settling/clarification of the juice prior to fermentation) and cool fermentation are to be the norm. (This is stylistic guidance as opposed to regulation.) 6) Chaptalization is permitted to a maximum of only a 2% increase in potential alcohol. 7) The wine will normally be vinified in Stainless Steel or other inert containers but, in any case, no more than 20% new oak barriques may be used for fermentation or storage, and the Independent Tasting Panel will be directed to fail wines in which the contribution of new oak overshadows the terroir-based aromatics or flavour of the wine. 8) The wine may or may not have gone through malolactic fermentation, but the Independent Tasting Panel will be directed to fail wines in which any effects of malolactic fermentation overshadow the terroir-based aromatics or flavour of the wine. 9) The maximum permitted alcohol content to be declared on the label is 11%. 10) The minimum permitted alcohol content to be declared on the label is 9.5%. 11) The total acidity of the wine at bottling must be 8g/l or greater, measured as tartaric, and no acid additions are allowed to achieve this minimum level in the component grapes. (**) 12) The maximum permitted residual sugar level is 20 grams/litre, however wines with higher acidity levels may exceed this maximum as long as the measurement of g/l of residual sugar is not more than double the wine's acidity, measured as tartaric. (By way of clarification, a wine with 12.5 g/l total acidity may have as much as 25g/l residual sugar.) The AIC recognizes that, independent of these wine analyses, the ITP may choose to reject a wine if it judges that it is atypical of the Appellation style, in being either too sweet or, alternatively, too severely dry. 13) No water additions are permitted. 14) The wine must be vintage-dated. 15) "Reserve" designations are not permitted. 16) A five person Independent Tasting Panel ("ITP") will established to approve those wines annually that may use the appellation. All wines must be submitted to, and must pass judgment by, the ITP, blind. Tank samples may be submitted for preliminary approval, but this approval may be revoked if a final bottled sample later fails. Wines will be scored using a simplified 5-Star ranking system (1-faulty, 2-dilute and/or atypical, 3-a pass, 4-fine, 5-exemplary). Reasons are to be given for a failure. No other feedback will be provided to the submitting winery. The identity of the evaluated wines will be revealed to the ITP only after the tasting, however, all submissions/scores/results will be confidential, and neither the judges nor the wineries may publically reveal that information. The AIC will work with the WANS Board to select the ITP members, using the following as a compositional guideline: - One NSLC wine expert - One or two wine writers - One or two wine educators - One or two sommeliers or wine store wine experts In addition to the five members, a sixth person will be regularly invited to participate as a non-voting, 'alternate' member of the ITP, for 'guest,' familiarization or training purposes, if agreed by the AIC. 17) It is expected that the ITP will convene commencing in February each year to facilitate a late May promotional launch of the wines, annually. 18) An appellation control system will be established for this wine, using a combination of monitoring, affidavit and inspection (in addition to the ITP) to fulfill the requirements envisioned. It is recognized that it will be necessary to phase this in over more than one vintage, but an affidavit system will be swiftly implemented in the interim. * The AIC recognizes those standards with a single asterisk will require a phase-in period to permit vineyards and wineries time to modify their current practices to meet the strict standards adopted above. (This is particularly essential for those standards that have been regulated 'retroactively' as they relate to the inaugural 2010 vintage of the appellation wine). (Accordingly, in view of the limited preparation time available to adjust practices to the above Appellation standards, the annual, bottled average of 3 Tonnes/Acre - - approx. 51hl/h - - as the maximum permitted yield, will commence with the 2011 vintage.) ** Exceptional vintages may be reviewed during the year in question and modified if considered necessary for quality assurance reasons, by the Technical & Standards Committee and the WANS Board. (NB: Such adjustments to winemaking standards in abnormal vintages are a normal part of, for example, the French Appelation Controlée standards.) (Accordingly, for the 2010 vintage, in view of an abnormally warm vintage of higher than normal crop levels - - and in line with the above - - the annual, bottled average of 3 Tonnes/Acre as the maximum permitted yield will commence with the 2011 vintage.) Judges Nominated and Approved by the WANS Board for the Independent Tasting Panel Peter Rockwell Sean Wood Mark DeWolf Craig Pinhey Carmen Mills Important Potential Alternates Suggested: Ron Crooks Jeff Pinhey Alanna McIntyre

Wine

Nova Scotia White Wine.

Paper for printing, publication, copying, faxing, writing and drawing.

Men's, ladies and children's swimwear namely, bathing suits, swim trunks and board shorts; men's, ladies and children's beachwear namely, wraps, shawls, sarongs, shorts, tank tops; men's, ladies and children's activewear namely, shirts, skirts, polo shirts, jersey's, fleece tops, pants, jackets, pullovers, capri pants, vests, sweaters and dresses.

Pharmaceutical preparations for the prevention and/or treatment of: cardiovascular disease; central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders, and smoking habits or addictions; neurological diseases and disorders, namely brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, cerebral palsy, multiple sclerosis; genitourinary diseases and disorders, namely urological diseases, urological disorders, infertility, sexually transmitted diseases, inflammatory pelvic diseases, premature ejaculation; gastrointestinal diseases and disorders; musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries; allergies; diabetes; hypertension; erectile dysfunction; sexual dysfunction; metabolic diseases and disorders; hemolytic diseases and disorders; cancer; migraines; pain, namely headaches, migraines, back pain, pain from burns, neuropathic pain, post-herpetic neuralgia; chronic pain; obesity; inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; the respiratory system; infectious diseases, namely respiratory infections, eye infections; immunological diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes, HIV, Acquired Immune Deficiency Syndrome (AIDS); viral diseases and disorders, namely herpes, hepatitis, HIV, Acquired Immune Deficiency Syndrome (AIDS); stroke; psychiatric diseases and disorders, namely mood disorders, anxiety disorders, panic disorders, bipolar disorder, cognitive disorders, schizophrenia, depression; substance abuse disorders, namely alcoholism and drug addiction; carpal tunnel syndrome; varicose veins; dental and oral diseases; osteoporosis; arthritis; multiple sclerosis; yeast infections; prostate disorders; pulmonary disorders; sleep disorders, namely, insomnia and restless leg syndrome; premature ejaculation; macular degeneration; thrombosis; and thromboembolism; (2) pharmaceutical preparations for: use in oncology; dermatology, namely dermatitis, skin pigmentation diseases; ophthalmology; ocular disorders; gastroenterology; and gynecology; (3) pharmaceutical preparations, namely cholesterol preparations, namely preparations to lower cholesterol; smoking cessation preparations; tissue and skin repair preparations; acne medication; allergy medication; antacids; anthelmintics; antiarrhythmics; antibiotics; anticoagulants; anticonvulsants; antidepressants; antiemetics; antiflatulants; antihistamines; antihypertensives; anti-infectives; anti-inflammatories; antiparasitics; antibacterials; antifungals; antivirals; burn relief medication; calcium channel blockers; central nervous system depressants; central nervous system stimulants; cough treatment medication; diarrhea medication; gastrointestinal medication; glaucoma agents; hydrocortisone; hypnotic agents; sedatives; and ophthalmic preparations.